Total visits last 3 months
| Last Month Change | 1.33% | 43.3% |
| Avg Visit Duration | 00:00:14 | 00:00:34 |
| Pages per Visit | 1.46 | 1.42 |
| Bounce Rate | 79.16% | 65.35% |
| Compare any site with a free trial | ||
newsroom.regeneron.com VS. 
eyleahdhcp.com
newsroom.regeneron.com
The Investor Relations website contains information about Regeneron Pharmaceuticals Inc.'s business for stockholders, potential investors, and financial analysts.
Global Rank
- -
eyleahdhcp.com
Discover EYLEA HD® (aflibercept) Injection. Approved for Wet AMD, DME, and DR. See Important Safety Info and Review Full Prescribing Information.
Global Rank
#1,743,867
newsroom.regeneron.com vs. eyleahdhcp.com Ranking Comparison
Compare newsroom.regeneron.com global ranking trend in the past 3 months vs. eyleahdhcp.com, or dive deeper into newsroom.regeneron.com ranking in its category or country measured against eyleahdhcp.com
Global Rank Last Month
newsroom.regeneron.com
--eyleahdhcp.com
#1,743,867
Traffic and Engagement
eyleahdhcp.com had more total visits compared to newsroom.regeneron.com in August 2026.
Traffic share by country: newsroom.regeneron.com vs. eyleahdhcp.com
newsroom.regeneron.com vs eyleahdhcp.com country based traffic analysis shows newsroom.regeneron.com gets the most traffic from United States, while eyleahdhcp.com gets a smaller share
Top Countries
newsroom.regeneron.com
56.37%
eyleahdhcp.com
43.63%
United States